U.S. Court of Appeals for the Federal Circuit, 2016

Pfizer Inc. v. Mylan Pharmaceuticals Inc.

Pfizer Inc. v. Mylan Pharmaceuticals Inc.
U.S. Court of Appeals for the Federal Circuit · Decided January 13, 2016

Pfizer Inc. v. Mylan Pharmaceuticals Inc.

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ PFIZER INC., PHARMACIA & UPJOHN COMPANY, PHARMACIA & UPJOHN COMPANY LLC, SUGEN, INC., C.P. PHARMACEUTICALS INTERNATIONAL C.V., PFIZER PHARMACEUTICALS LLC, PF PRISM C.V., Plaintiffs-Appellees v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant ______________________ 2015-1131 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:10-cv-00528-GMS, Judge Gregory M. Sleet. ______________________ JUDGMENT ______________________ THOMAS H.L. SELBY, Williams & Connolly LLP, Wash- ington, DC, argued for plaintiffs-appellees. Also repre- sented by STANLEY E. FISHER, JESSAMYN SHELI BERNIKER, SARA KAISER CREIGHTON.

DOUGLAS H. CARSTEN, Wilson, Sonsini, Goodrich & Rosati, PC, San Diego, CA, argued for defendant- appellant. Also represented by PETER SOO KANG; KATHERINE HASPER, Palo Alto, CA; ROBERT DELAFIELD, Austin, TX. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (DYK, WALLACH, and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

January 13, 2016 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.